Skip to main content
TipRanks
Go Ultimate75% OFF

Mediwound (MDWD) Stock Statistics & Valuation Metrics

467 Followers

Total Valuation

Mediwound has a market cap or net worth of $176.61M. The enterprise value is $160.05M.

Market Cap
$176.61M
Enterprise Value
$160.05M

Share Statistics

Mediwound has 12,910,278 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
12,910,278
Owned by Insiders
1.65%
Owned by Institutions
40.63%

Financial Efficiency

Mediwound’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -41.75%.

Return on Equity (ROE)
-0.55
Return on Assets (ROA)
-0.28
Return on Invested Capital (ROIC)
-41.75%
Return on Capital Employed (ROCE)
-0.42
Revenue Per Employee
140.16K
Profits Per Employee
-197.35K
Employee Count
121
Asset Turnover
0.20
Inventory Turnover
3.35

Valuation Ratios

The current PE Ratio of Mediwound is -7.52. Mediwound’s PEG ratio is 0.95.

PE Ratio
-7.52
PS Ratio
17.65
PB Ratio
5.58
Price to FCF
-5.42
Price to Operating Cash Flow
-6.72
PEG Ratio
0.95

Income Statement

In the last 12 months, Mediwound had revenue of 16.96M and earned -23.88M in profits. Earnings per share was -2.10.

Revenue
16.96M
Gross Profit
3.25M
Operating Income
-25.28M
Pretax Income
-23.71M
Net Income
-23.88M
EBITDA
-21.47M
Earnings Per Share (EPS)
-2.10

Cash Flow

In the last 12 months, operating cash flow was -26.41M and capital expenditures -6.14M, giving a free cash flow of -32.56M billion.

Operating Cash Flow
-26.41M
Free Cash Flow
-32.56M
Free Cash Flow per Share
-2.51

Dividends & Yields

Mediwound pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-18.41%
Earnings Yield
-13.23%

Stock Price Statistics

Beta
0.85
52-Week Price Change
-25.57%
50-Day Moving Average
13.20
200-Day Moving Average
15.00
Relative Strength Index (RSI)
53.79
Average Volume (3m)
120.90K

Important Dates

Mediwound upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Mediwound as a current ratio of 2.33, with Debt / Equity ratio of 18.68%

Current Ratio
2.33
Quick Ratio
2.17
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.16
Interest Coverage Ratio
-38.13

Taxes

In the past 12 months, Mediwound has paid 169.00K in taxes.

Income Tax
169.00K
Effective Tax Rate
-0.01

Enterprise Valuation

Mediwound EV to EBITDA ratio is -6.30, with an EV/FCF ratio of -4.83.

EV to Sales
15.72
EV to EBITDA
-6.30
EV to Free Cash Flow
-4.83
EV to Operating Cash Flow
-5.96

Balance Sheet

Mediwound has $27.85M in cash and marketable securities with $8.30M in debt, giving a net cash position of $19.55M billion.

Cash & Marketable Securities
$27.85M
Total Debt
$8.30M
Net Cash
$19.55M
Net Cash Per Share
$1.51
Tangible Book Value Per Share
$2.45

Margins

Gross margin is 19.54%, with operating margin of -337.76%, and net profit margin of -234.98%.

Gross Margin
19.54%
Operating Margin
-337.76%
Pretax Margin
-233.25%
Net Profit Margin
-234.98%
EBITDA Margin
-249.65%
EBIT Margin
-268.21%

Analyst Forecast

The average price target for Mediwound is $29.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$29.67
Price Target Upside
116.86% Upside
Analyst Consensus
Strong Buy
Analyst Count
6
Revenue Growth Forecast
-52.19%
EPS Growth Forecast
3.91%

Scores

Smart Score
8
AI Score
46